Three Biotechs Raise $320M in IPOs, Two Others Pass on Wall Street

With five biotech IPOs on the calendar, this week was expected to be a big one. Three companies ended up making Wall Street debuts, raising a combined $320 million, led by Viela Bio. But two other firms didn’t like the market conditions and decided against going public for now. Here’s a recap of the week’s biotech IPO activity so far: